Clinical Outcomes of Delayed Clearance of Serum HBsAg in Patients with Chronic HBV Infection
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background : Spontaneous delayed clearance of hepatitis B surface antigen (HBsAg) in patients with chronic HBV infection is a rare event. The aim of this study was to investigate the incidence of delayed clearance of serum HBsAg in chronic HBV infection and to determine the characteristics and clinical outcomes of HBsAg delayed clearance in Korean patients. Methods : From April 1981 to June 2003, 4,061 patients who were positive for HBsAg were evaluated retrospectively. The following assessments were undertaken in 47 patients who had spontaneous delayed clearance: liver biochemistry, viral markers, α-fetoprotein levels, and radiographic examinations including ultrasonography every three to six months for 6-264 months (median 87.9 months). Results : Twenty-four of 47 patients were asymptomatic carriers. The others included seven patients with chronic hepatitis, seven with liver cirrhosis and nine with hepatocellular carcinoma. The estimated annual incidence of HBsAg seroclearance was 0.4%. The time span from positive HBsAg to HBsAg seroclearance in the AHC, CH, LC, and HCC was 62.9, 141, 63, and 95.3 months during follow up. Twenty-four of 24 AHC remained normal, 5 of 7 CH remained as CH and 2 patients remained normal, 1 of 7 with LC developed HCC and 6 of the LC remained as LC, and 4 of 9 HCC patients died. Conclusion : The clinical course following delayed clearance of HBsAg had diverse outcomes from AHC to HCC. Therefore, these patients require close follow up for the possible development of hepatocellular carcinoma following HBsAg clearance.
Abstract
Background : Spontaneous delayed clearance of hepatitis B surface antigen (HBsAg) in patients with chronic HBV infection is a rare event. The aim of this study was to investigate the incidence of delayed clearance of serum HBsAg in chronic HBV infection and to determine the characteristics and clinical outcomes of HBsAg delayed clearance in Korean patients. Methods : From April 1981 to June 2003, 4,061 patients who were positive for HBsAg were evaluated retrospectively. The following assessments were undertaken in 47 patients who had spontaneous delayed clearance: liver biochemistry, viral markers, α-fetoprotein levels, and radiographic examinations including ultrasonography every three to six months for 6-264 months (median 87.9 months). Results : Twenty-four of 47 patients were asymptomatic carriers. The others included seven patients with chronic hepatitis, seven with liver cirrhosis and nine with hepatocellular carcinoma. The estimated annual incidence of HBsAg seroclearance was 0.4%. The time span from positive HBsAg to HBsAg seroclearance in the AHC, CH, LC, and HCC was 62.9, 141, 63, and 95.3 months during follow up. Twenty-four of 24 AHC remained normal, 5 of 7 CH remained as CH and 2 patients remained normal, 1 of 7 with LC developed HCC and 6 of the LC remained as LC, and 4 of 9 HCC patients died. Conclusion : The clinical course following delayed clearance of HBsAg had diverse outcomes from AHC to HCC. Therefore, these patients require close follow up for the possible development of hepatocellular carcinoma following HBsAg clearance.
참고문헌 (24)
- "The development of cirrhosis in patients with chronic type B hepatitis", pp.493~8 496 (1988)
- "Natural history of chronic hepatitis B virus infection", pp.9~18 (1986)
- "The natural history of asymptomatic hepatitis B surface antigen carriers"
- "Natural history of liver disease in chronic hepatitis B surface antigen carriers", pp.1156~2 1159 (1981)
- "Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers", 145, pp.1039~1047 (1997)
- "Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan", pp.1129~2 1133 (1981), Lin CC
- "Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan", 35, pp.201~205 (2000)
- "Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection", 123, pp.1084~1089 (2002)
- "Delayed HBsAg clearance in chronic hepatitis B viral infection", pp.586~1 589 (1981)
- "Clearance of hepatitis B surface antigen after surgical resection of hepatocellular carcinoma", pp.45~51 (1987)
- "determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection", pp.627~13 631 (1991), Incidence
- "From hepatitis to hepatoma lessons from type B viral hepatitis", pp.369~262 370 (1993)
- "Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis", 93, pp.896~900 (1998)
- "Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis", 28, pp.231~236 (1998)
- "Long-term follow-up of hepatitis B virus carriers with normal transaminases levels", 40, pp.365~372 (1998)
- "Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis: lack of correlation with hepatitis C and D virus superinfection", 31, pp.696~701 (1996)
- "Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state a multivariate analysis in a longitudinal follow-up study", pp.358~361 (1994)
- "Role of hepatitis C virus in dual and triple hepatitis virus infection", 22, pp.1101~1108 (1995)
- "Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen", 18, pp.1129~1138 (2003)
- "Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis", pp.1048~106 1053 (1994)
- "The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease", 22, pp.38~41 (1995)
- "Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma", pp.98~14 102 (1994)
- "The liver histology and frequency of clearance of the hepatitis B surface antigen", pp.17~22 (1979), in chronic carriers
- "The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma", pp.604~609 (1985)